Growth Metrics

Sarepta Therapeutics (SRPT) Operating Income Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.69%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -347.04%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 80.62%
7 Evaxion A 62.56 Bn 62.54 Bn - 1.27%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,386.07%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn 219.32%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 219.32%
Dec 31, 2025 -354.56%
Sep 30, 2025 -565.80%
Jun 30, 2025 16,587.45%
Mar 31, 2025 -960.58%
Dec 31, 2024 556.57%
Sep 30, 2024 206.50%
Jun 30, 2024 99.47%
Mar 31, 2024 125.28%
Dec 31, 2023 123.05%
Sep 30, 2023 84.13%
Jun 30, 2023 36.76%
Mar 31, 2023 -58.94%
Dec 31, 2022 -0.96%
Sep 30, 2022 -281.20%
Jun 30, 2022 -25.99%
Mar 31, 2022 42.79%
Dec 31, 2021 38.02%
Sep 30, 2021 74.86%
Jun 30, 2021 -21.12%
Mar 31, 2021 -28.67%
Dec 31, 2020 25.85%
Sep 30, 2020 -10.91%
Jun 30, 2020 49.76%
Mar 31, 2020 -54.51%
Dec 31, 2019 -65.19%
Sep 30, 2019 -76.31%
Jun 30, 2019 -166.24%
Mar 31, 2019 -148.50%
Dec 31, 2018 -502.08%
Sep 30, 2018 -52.70%
Jun 30, 2018 -63.29%
Mar 31, 2018 21.67%
Dec 31, 2017 73.81%
Sep 30, 2017 18.80%
Jun 30, 2017 -2.00%
Mar 31, 2017 34.27%
Dec 31, 2016 -37.15%
Sep 30, 2016 -9.22%
Jun 30, 2016 -47.48%
Mar 31, 2016 3.49%
Dec 31, 2015 -44.12%
Sep 30, 2015 -53.71%
Jun 30, 2015 -39.10%
Mar 31, 2015 -146.26%
Dec 31, 2014 -36.14%
Sep 30, 2014 -35.06%
Jun 30, 2014 -77.16%
Mar 31, 2014 -62.96%
Dec 31, 2013 -216.89%
Sep 30, 2013 -261.09%
Jun 30, 2013 -207.49%
Mar 31, 2013 -124.25%
Dec 31, 2012 -15.18%
Sep 30, 2012 38.74%
Jun 30, 2012 45.12%
Mar 31, 2012 -24.28%
Dec 31, 2011 -417.24%
Sep 30, 2011 -196.84%
Jun 30, 2011 -32.06%